Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16271083

Download in:

View as

General Info

PMID
16271083